M. Neale Weitzmann, PhD

Research Program

Discovery and Developmental Therapeutics
Phone Number

404-727-1389
Email Address

mweitzm@emory.edu

Biography

M. Neale Weitzmann, PhD, is Professor of Medicine and an associate director of the Bone Laboratory in the Division of Endocrinology and Metabolism at Emory University School of Medicine. Dr. Weitzmann is also a research biologist at the Department of Veterans Affairs, Atlanta VA Medical Center. He is a member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute.

Education

Dr. Weitzmann received his PhD in Medical Biochemistry from Medical School, University of the Witwatersrand at Johannesburg, South Africa. His postdoctoral training included a fellowship in the Laboratory of Molecular and Cellular Biology at the National Institutes of Health in Bethesda, MD. He also completed a fellowship in the Department of Internal Medicine at the Washington University School of Medicine in St. Louis, MO.

Titles & Roles

Professor, Department of Medicine

Emory University School of Medicine

Research

Dr. Weitzmann's research focus centers on metabolic bone disease and the mechanisms that drive bone loss in multiple pathological conditions including rheumatoid arthritis, aging, postmenopausal osteoporosis, HIV-infection, antiretroviral therapy and cancer metastases to bone.

Publications

Title/Journal	Authors	Publication Date
Combined Sequential Antiretroviral Therapy-Induced Immune Reconstitution Bone Loss and Estrogen Deficiency Bone Loss Are Cumulative in Mice Models. The Journal of infectious diseases	S Dabeer, AK Tripathi, D Weiss, T Vikulina, I Ofotokun, MN Weitzmann	04/15/2025
The impact of childhood maltreatment, HIV status, and their interaction on mental health outcomes and markers of systemic inflammation in women. Biology of sex differences	A Arnold, H Wang, CC Mehta, PC Nesbeth, B Bedi, C Kirkpatrick, CA Moran, A Powers, AK Smith, K Hagen, MN Weitzmann, I Ofotokun, CD Lahiri, JA Alvarez, AA Quyyumi, GN Neigh, V Michopoulos	03/28/2025
Hydroxyurea blunts mitochondrial energy metabolism and osteoblast and osteoclast differentiation exacerbating trabecular bone loss in sickle cell mice. Cell death & disease	AK Tripathi, S Dabeer, J Song, T Vikulina, S Roser-Page, JA Alvarez, DR Archer, MN Weitzmann	12/18/2024
Gender-affirming hormone therapy preserves skeletal maturation in young mice via the gut microbiome. The Journal of clinical investigation	S Pal, X Morgan, HY Dar, CA Gacasan, S Patil, A Stoica, YJ Hu, MN Weitzmann, RM Jones, R Pacifici	03/26/2024
Linoleic acid blunts early osteoblast differentiation and impairs oxidative phosphorylation in vitro. Prostaglandins, leukotrienes, and essential fatty acids	PC Nesbeth, TR Ziegler, AK Tripathi, S Dabeer, D Weiss, L Hao, MR Smith, DP Jones, KM Maner-Smith, CL Tu, W Chang, MN Weitzmann, JA Alvarez	02/01/2024
Loss of Ptpmt1 limits mitochondrial utilization of carbohydrates and leads to muscle atrophy and heart failure in tissue-specific knockout mice. eLife	H Zheng, Q Li, S Li, Z Li, M Brotto, D Weiss, D Prosdocimo, C Xu, A Reddy, M Puchowicz, X Zhao, MN Weitzmann, MK Jain, CK Qu	09/06/2023
Callus γδ T cells and microbe-induced intestinal Th17 cells improve fracture healing in mice. The Journal of clinical investigation	HY Dar, DS Perrien, S Pal, A Stoica, S Uppuganti, JS Nyman, RM Jones, MN Weitzmann, R Pacifici	04/17/2023
Hormone therapy and fractures in postmenopausal women. AIDS (London, England)	MT Yin, DR Hoover, Q Shi, PC Tien, MH Cohen, S Kassaye, D Gustafson, A Adimora, MN Weitzmann, H Bolivar, A Warriner, SH Bares, A Sharma	10/01/2022
Immune Reconstitution Bone Loss Exacerbates Bone Degeneration Due to Natural Aging in a Mouse Model. The Journal of infectious diseases	MN Weitzmann, D Weiss, T Vikulina, S Roser-Page, K Yu, ME McGee-Lawrence, CL Tu, W Chang, I Ofotokun	08/12/2022
Cyclic Adenosine Monophosphate (cAMP)-Dependent Phosphodiesterase Inhibition Promotes Bone Anabolism Through CD8⁺ T Cell Wnt-10b Production in Mice. JBMR plus	S Roser-Page, D Weiss, T Vikulina, M Yu, R Pacifici, MN Weitzmann	07/01/2022
The microbiome restrains melanoma bone growth by promoting intestinal NK and Th1 cell homing to bone. The Journal of clinical investigation	S Pal, DS Perrien, T Yumoto, R Faccio, A Stoica, J Adams, CM Coopersmith, RM Jones, MN Weitzmann, R Pacifici	06/15/2022
The effect of age on CD4+ T-cell recovery in HIV-suppressed adult participants: a sub-study from AIDS Clinical Trial Group (ACTG) A5321 and the Bone Loss and Immune Reconstitution (BLIR) study. Immunity & ageing : I & A	J Chen, K Titanji, AN Sheth, R Gandhi, D McMahon, I Ofotokun, MN Weitzmann, K De Paris, JB Dumond	01/03/2022
Bone, Brain, Heart study protocol: A resilient nested, tripartite prospective cohort study of the role of estrogen depletion on HIV pathology. PloS one	CC Mehta, KS Hagen, AA Rubtsova, CD Lahiri, V Michopoulos, CA Moran, LB Haddad, K Titanji, LF Collins, AA Quyyumi, G Neigh, LJ Shaw, MN Weitzmann, L Waller, I Ofotokun	01/01/2022
Restriction of HIV-1 infection in sickle cell trait. Blood advances	N Kumari, M Nouraie, A Ahmad, H Lassiter, J Khan, S Diaz, N Afangbedji, S Wang, PE Houston, T Ammosova, M de Mulder Rougvie, S Rana, DF Nixon, K Anastos, J Lazar, AL French, S Gange, AA Adimora, MN Weitzmann, M Fischl, MC Kempf, S Kassaye, JG Taylor, S Nekhai	12/14/2021
Ovariectomy induces bone loss via microbial-dependent trafficking of intestinal TNF+ T cells and Th17 cells. The Journal of clinical investigation	M Yu, S Pal, CW Paterson, JY Li, AM Tyagi, J Adams, CM Coopersmith, MN Weitzmann, R Pacifici	02/15/2021
Plasma high-resolution metabolomics identifies linoleic acid and linked metabolic pathways associated with bone mineral density. Clinical nutrition (Edinburgh, Scotland)	MP Bellissimo, TR Ziegler, DP Jones, KH Liu, J Fernandes, JL Roberts, MN Weitzmann, R Pacifici, JA Alvarez	02/01/2021
Antiretroviral Therapy-Induced Bone Loss Is Durably Suppressed by a Single Dose of Zoledronic Acid in Treatment-Naive Persons with Human Immunodeficiency Virus Infection: A Phase IIB Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America	I Ofotokun, LF Collins, K Titanji, A Foster, CA Moran, AN Sheth, CD Lahiri, JL Lennox, L Ward, KA Easley, MN Weitzmann	10/23/2020
Metabolomic Associations with Serum Bone Turnover Markers. Nutrients	MP Bellissimo, JL Roberts, DP Jones, KH Liu, KR Taibl, K Uppal, MN Weitzmann, R Pacifici, H Drissi, TR Ziegler, JA Alvarez	10/16/2020
Immature/transitional B-cell expansion is associated with bone loss in HIV-infected individuals with severe CD4+ T-cell lymphopenia. AIDS (London, England)	K Titanji, I Ofotokun, MN Weitzmann	08/01/2020
Parathyroid hormone-dependent bone formation requires butyrate production by intestinal microbiota. The Journal of clinical investigation	JY Li, M Yu, S Pal, AM Tyagi, H Dar, J Adams, MN Weitzmann, RM Jones, R Pacifici	04/01/2020
PTH induces bone loss via microbial-dependent expansion of intestinal TNF⁺ T cells and Th17 cells. Nature communications	M Yu, A Malik Tyagi, JY Li, J Adams, TL Denning, MN Weitzmann, RM Jones, R Pacifici	01/24/2020
Reduced bone formation in males and increased bone resorption in females drive bone loss in hemophilia A mice. Blood advances	MN Weitzmann, S Roser-Page, T Vikulina, D Weiss, L Hao, WH Baldwin, K Yu, N Del Mazo Arbona, ME McGee-Lawrence, SL Meeks, CL Kempton	02/12/2019
IL-17 Receptor Signaling in Osteoblasts/Osteocytes Mediates PTH-Induced Bone Loss and Enhances Osteocytic RANKL Production. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research	JY Li, M Yu, AM Tyagi, C Vaccaro, E Hsu, J Adams, T Bellido, MN Weitzmann, R Pacifici	02/01/2019
The Microbial Metabolite Butyrate Stimulates Bone Formation via T Regulatory Cell-Mediated Regulation of WNT10B Expression. Immunity	AM Tyagi, M Yu, TM Darby, C Vaccaro, JY Li, JA Owens, E Hsu, J Adams, MN Weitzmann, RM Jones, R Pacifici	12/18/2018
Neutralization of CD40 ligand costimulation promotes bone formation and accretion of vertebral bone mass in mice. Rheumatology (Oxford, England)	S Roser-Page, T Vikulina, K Yu, ME McGee-Lawrence, MN Weitzmann	06/01/2018
T-cell receptor activator of nuclear factor-κB ligand/osteoprotegerin imbalance is associated with HIV-induced bone loss in patients with higher CD4+ T-cell counts. AIDS (London, England)	K Titanji, A Vunnava, A Foster, AN Sheth, JL Lennox, A Knezevic, N Shenvi, KA Easley, I Ofotokun, MN Weitzmann	04/24/2018
CTLA-4Ig (abatacept) balances bone anabolic effects of T cells and Wnt-10b with antianabolic effects of osteoblastic sclerostin. Annals of the New York Academy of Sciences	S Roser-Page, T Vikulina, D Weiss, MM Habib, GR Beck, R Pacifici, TF Lane, MN Weitzmann	03/01/2018
Regulatory T cells are expanded by Teriparatide treatment in humans and mediate intermittent PTH-induced bone anabolism in mice. EMBO reports	M Yu, P D'Amelio, AM Tyagi, C Vaccaro, JY Li, E Hsu, I Buondonno, F Sassi, J Adams, MN Weitzmann, R DiPaolo, R Pacifici	01/01/2018
Homeostatic Expansion of CD4+ T Cells Promotes Cortical and Trabecular Bone Loss, Whereas CD8+ T Cells Induce Trabecular Bone Loss Only. The Journal of infectious diseases	MN Weitzmann, T Vikulina, S Roser-Page, M Yamaguchi, I Ofotokun	11/27/2017
Bone and the Immune System. Toxicologic pathology	MN Weitzmann	10/01/2017
Survival of lung cancer patients is prolonged with higher regucalcin gene expression: suppressed proliferation of lung adenocarcinoma A549 cells in vitro. Molecular and cellular biochemistry	M Yamaguchi, S Osuka, M Shoji, MN Weitzmann, T Murata	06/01/2017
Bone Loss in HIV Infection. Current treatment options in infectious diseases	CA Moran, MN Weitzmann, I Ofotokun	03/01/2017
Persistence of Vascular Calcification after Reversal of Uremia. The American journal of pathology	KA Lomashvili, KE Manning, MN Weitzmann, V Nelea, MD McKee, WC O'Neill	02/01/2017
GNB3 overexpression causes obesity and metabolic syndrome. PloS one	AC Ozdemir, GM Wynn, A Vester, MN Weitzmann, GN Neigh, S Srinivasan, MK Rudd	01/01/2017
Bone Loss Among Women Living With HIV. Current HIV/AIDS reports	MN Weitzmann, I Ofotokun, K Titanji, A Sharma, MT Yin	12/01/2016
Prolonged survival in hepatocarcinoma patients with increased regucalcin gene expression: HepG2 cell proliferation is suppressed by overexpression of regucalcin in vitro. International journal of oncology	M Yamaguchi, S Osuka, MN Weitzmann, BF El-Rayes, M Shoji, T Murata	10/01/2016
A Single-dose Zoledronic Acid Infusion Prevents Antiretroviral Therapy-induced Bone Loss in Treatment-naive HIV-infected Patients: A Phase IIb Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America	I Ofotokun, K Titanji, CD Lahiri, A Vunnava, A Foster, SE Sanford, AN Sheth, JL Lennox, A Knezevic, L Ward, KA Easley, P Powers, MN Weitzmann	09/01/2016
Physiological and pathophysiological bone turnover - role of the immune system. Nature reviews. Endocrinology	MN Weitzmann, I Ofotokun	09/01/2016
Differential CD4+ cell count increase and CD4+ : CD8+ ratio normalization with maraviroc compared with tenofovir. AIDS (London, England)	ES Chan, AL Landay, TT Brown, HJ Ribaudo, P Mirmonsef, I Ofotokun, MN Weitzmann, J Martinson, KL Klingman, JJ Eron, CJ Fichtenbaum, J Plants, BO Taiwo	08/24/2016
Increased regucalcin gene expression extends survival in breast cancer patients: Overexpression of regucalcin suppresses the proliferation and metastatic bone activity in MDA-MB-231 human breast cancer cells in vitro. International journal of oncology	M Yamaguchi, S Osuka, MN Weitzmann, M Shoji, T Murata	08/01/2016
The protease inhibitors and HIV-associated bone loss. Current opinion in HIV and AIDS	CA Moran, MN Weitzmann, I Ofotokun	05/01/2016
Prolonged survival in pancreatic cancer patients with increased regucalcin gene expression: Overexpression of regucalcin suppresses the proliferation in human pancreatic cancer MIA PaCa-2 cells in vitro. International journal of oncology	M Yamaguchi, S Osuka, MN Weitzmann, BF El-Rayes, M Shoji, T Murata	05/01/2016
Expression of SOFAT by T- and B-lineage cells may contribute to bone loss. Molecular medicine reports	CR Jarry, EF Martinez, DC Peruzzo, V Carregaro, LA Sacramento, VC Araújo, MN Weitzmann, MH Napimoga	05/01/2016
Antiretroviral therapy induces a rapid increase in bone resorption that is positively associated with the magnitude of immune reconstitution in HIV infection. AIDS (London, England)	I Ofotokun, K Titanji, A Vunnava, S Roser-Page, T Vikulina, F Villinger, K Rogers, AN Sheth, CD Lahiri, JL Lennox, MN Weitzmann	01/28/2016
IL-17A Is Increased in Humans with Primary Hyperparathyroidism and Mediates PTH-Induced Bone Loss in Mice. Cell metabolism	JY Li, P D'Amelio, J Robinson, LD Walker, C Vaccaro, T Luo, AM Tyagi, M Yu, M Reott, F Sassi, I Buondonno, J Adams, MN Weitzmann, GC Isaia, R Pacifici	11/03/2015
The flavonoid p-hydroxycinnamic acid mediates anticancer effects on MDA-MB-231 human breast cancer cells in vitro: Implications for suppression of bone metastases. International journal of oncology	M Yamaguchi, T Murata, M Shoji, MN Weitzmann	10/01/2015
Gentian violet inhibits MDA-MB-231 human breast cancer cell proliferation, and reverses the stimulation of osteoclastogenesis and suppression of osteoblast activity induced by cancer cells. Oncology reports	M Yamaguchi, T Vikulina, MN Weitzmann	10/01/2015
Role of T-cell reconstitution in HIV-1 antiretroviral therapy-induced bone loss. Nature communications	I Ofotokun, K Titanji, T Vikulina, S Roser-Page, M Yamaguchi, M Zayzafoon, IR Williams, MN Weitzmann	09/22/2015
Bioactive silica nanoparticles reverse age-associated bone loss in mice. Nanomedicine : nanotechnology, biology, and medicine	MN Weitzmann, SW Ha, T Vikulina, S Roser-Page, JK Lee, GR Beck	05/01/2015
T cell-expressed CD40L potentiates the bone anabolic activity of intermittent PTH treatment. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research	JW Robinson, JY Li, LD Walker, AM Tyagi, MA Reott, M Yu, J Adams, MN Weitzmann, R Pacifici	04/01/2015
Curcumin analog UBS109 prevents bone marrow osteoblastogenesis and osteoclastogenesis disordered by coculture with breast cancer MDA-MB-231 bone metastatic cells in vitro. Molecular and cellular biochemistry	M Yamaguchi, S Zhu, MN Weitzmann, JP Snyder, M Shoji	03/01/2015
Body composition and grip strength are improved in transgenic sickle mice fed a high-protein diet. Journal of nutritional science	PL Capers, HI Hyacinth, S Cue, P Chappa, T Vikulina, S Roser-Page, MN Weitzmann, DR Archer, GW Newman, A Quarshie, JK Stiles, JM Hibbert	01/01/2015
T-cells and B-cells in osteoporosis. Current opinion in endocrinology, diabetes, and obesity	MN Weitzmann	12/01/2014
Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection. PLoS pathogens	K Titanji, A Vunnava, AN Sheth, C Delille, JL Lennox, SE Sanford, A Foster, A Knezevic, KA Easley, MN Weitzmann, I Ofotokun	10/01/2014
Bioactive silica nanoparticles promote osteoblast differentiation through stimulation of autophagy and direct association with LC3 and p62. ACS nano	SW Ha, MN Weitzmann, GR Beck	06/24/2014
CTLA-4Ig-induced T cell anergy promotes Wnt-10b production and bone formation in a mouse model. Arthritis & rheumatology (Hoboken, N.J.)	S Roser-Page, T Vikulina, M Zayzafoon, MN Weitzmann	04/01/2014
Bio-active engineered 50 nm silica nanoparticles with bone anabolic activity: therapeutic index, effective concentration, and cytotoxicity profile in vitro. Toxicology in vitro : an international journal published in association with BIBRA	SW Ha, JA Sikorski, MN Weitzmann, GR Beck	04/01/2014
Suppression of NF-κB activation by gentian violet promotes osteoblastogenesis and suppresses osteoclastogenesis. Current molecular medicine	M Yamaguchi, T Vikulina, JL Arbiser, MN Weitzmann	01/01/2014
The sclerostin-independent bone anabolic activity of intermittent PTH treatment is mediated by T-cell-produced Wnt10b. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research	JY Li, LD Walker, AM Tyagi, J Adams, MN Weitzmann, R Pacifici	01/01/2014
B Cell Production of Both OPG and RANKL is Significantly Increased in Aged Mice. The Open bone journal	Y Li, M Terauchi, T Vikulina, S Roser-Page, MN Weitzmann	01/01/2014
Bone loss in surgically ovariectomized premenopausal women is associated with T lymphocyte activation and thymic hypertrophy. Journal of investigative medicine : the official publication of the American Federation for Clinical Research	S Adeel, K Singh, KH Vydareny, M Kumari, E Shah, MN Weitzmann, V Tangpricha	12/01/2013
Ovariectomy expands murine short-term hemopoietic stem cell function through T cell expressed CD40L and Wnt10B. Blood	JY Li, J Adams, LM Calvi, TF Lane, MN Weitzmann, R Pacifici	10/03/2013
Link protein N-terminal peptide binds to bone morphogenetic protein (BMP) type II receptor and drives matrix protein expression in rabbit intervertebral disc cells. The Journal of biological chemistry	Z Wang, MN Weitzmann, S Sangadala, WC Hutton, ST Yoon	09/27/2013
Do γδ T cells predict osteonecrosis of the jaw? Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research	MN Weitzmann	04/01/2013
The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis. Scientifica	MN Weitzmann	01/01/2013
PTH expands short-term murine hemopoietic stem cells through T cells. Blood	JY Li, J Adams, LM Calvi, TF Lane, R DiPaolo, MN Weitzmann, R Pacifici	11/22/2012
The bone anabolic carotenoid p-hydroxycinnamic acid promotes osteoblast mineralization and suppresses osteoclast differentiation by antagonizing NF-κB activation. International journal of molecular medicine	M Yamaguchi, MN Weitzmann	09/01/2012
Bioactive silica-based nanoparticles stimulate bone-forming osteoblasts, suppress bone-resorbing osteoclasts, and enhance bone mineral density in vivo. Nanomedicine : nanotechnology, biology, and medicine	GR Beck, SW Ha, CE Camalier, M Yamaguchi, Y Li, JK Lee, MN Weitzmann	08/01/2012
High dose 1,25(OH)2D3 inhibits osteoblast mineralization in vitro. International journal of molecular medicine	M Yamaguchi, MN Weitzmann	05/01/2012
Silencing of parathyroid hormone (PTH) receptor 1 in T cells blunts the bone anabolic activity of PTH. Proceedings of the National Academy of Sciences of the United States of America	B Bedi, JY Li, H Tawfeek, KH Baek, J Adams, SS Vangara, MK Chang, M Kneissel, MN Weitzmann, R Pacifici	03/20/2012
HIV: inflammation and bone. Current HIV/AIDS reports	I Ofotokun, E McIntosh, MN Weitzmann	03/01/2012
Exogenous regucalcin stimulates osteoclastogenesis and suppresses osteoblastogenesis through NF-κB activation. Molecular and cellular biochemistry	M Yamaguchi, MN Weitzmann, T Murata	01/01/2012
The intact strontium ranelate complex stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-κB activation. Molecular and cellular biochemistry	M Yamaguchi, MN Weitzmann	01/01/2012
Honokiol stimulates osteoblastogenesis by suppressing NF-κB activation. International journal of molecular medicine	M Yamaguchi, JL Arbiser, MN Weitzmann	12/01/2011
Quercetin, a potent suppressor of NF-κB and Smad activation in osteoblasts. International journal of molecular medicine	M Yamaguchi, MN Weitzmann	10/01/2011
A new regulator of osteoclastogenesis: estrogen response element-binding protein in bone. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research	H Chen, LC Gilbert, X Lu, Z Liu, S You, MN Weitzmann, MS Nanes, J Adams	10/01/2011
Zinc stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-κB activation. Molecular and cellular biochemistry	M Yamaguchi, MN Weitzmann	09/01/2011
HIV and bone metabolism. Discovery medicine	I Ofotokun, MN Weitzmann	05/01/2011
β2-microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bone metastasis in human cancer cells. Cancer research	S Josson, T Nomura, JT Lin, WC Huang, D Wu, HE Zhau, M Zayzafoon, MN Weizmann, M Gururajan, LW Chung	04/01/2011
Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand. Proceedings of the National Academy of Sciences of the United States of America	JY Li, H Tawfeek, B Bedi, X Yang, J Adams, KY Gao, M Zayzafoon, MN Weitzmann, R Pacifici	01/11/2011
Vitamin K2 stimulates osteoblastogenesis and suppresses osteoclastogenesis by suppressing NF-κB activation. International journal of molecular medicine	M Yamaguchi, MN Weitzmann	01/01/2011
HIV-1 infection and antiretroviral therapies: risk factors for osteoporosis and bone fracture. Current opinion in endocrinology, diabetes, and obesity	I Ofotokun, MN Weitzmann	12/01/2010
Disruption of PTH receptor 1 in T cells protects against PTH-induced bone loss. PloS one	H Tawfeek, B Bedi, JY Li, J Adams, T Kobayashi, MN Weitzmann, HM Kronenberg, R Pacifici	08/20/2010
Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats. Proceedings of the National Academy of Sciences of the United States of America	T Vikulina, X Fan, M Yamaguchi, S Roser-Page, M Zayzafoon, DM Guidot, I Ofotokun, MN Weitzmann	08/03/2010
Inhibition of antigen presentation and T cell costimulation blocks PTH-induced bone loss. Annals of the New York Academy of Sciences	B Bedi, JY Li, F Grassi, H Tawfeek, MN Weitzmann, R Pacifici	03/01/2010
The bone anabolic carotenoid beta-cryptoxanthin enhances transforming growth factor-beta1-induced SMAD activation in MC3T3 preosteoblasts. International journal of molecular medicine	M Yamaguchi, MN Weitzmann	11/01/2009
T lymphocytes amplify the anabolic activity of parathyroid hormone through Wnt10b signaling. Cell metabolism	M Terauchi, JY Li, B Bedi, KH Baek, H Tawfeek, S Galley, L Gilbert, MS Nanes, M Zayzafoon, R Guldberg, DL Lamar, MA Singer, TF Lane, HM Kronenberg, MN Weitzmann, R Pacifici	09/01/2009
The estrogen 17beta-estradiol and phytoestrogen genistein mediate differential effects on osteoblastic NF-kappaB activity. International journal of molecular medicine	M Yamaguchi, MN Weitzmann	02/01/2009
The bone anabolic carotenoids p-hydroxycinnamic acid and β-cryptoxanthin antagonize NF-κB activation in MC3T3 preosteoblasts. Molecular medicine reports	M Yamaguchi, MN Weitzmann	01/01/2009
T cells potentiate PTH-induced cortical bone loss through CD40L signaling. Cell metabolism	Y Gao, X Wu, M Terauchi, JY Li, F Grassi, S Galley, X Yang, MN Weitzmann, R Pacifici	08/01/2008
Suppression of NF-kappaB activation blocks osteoclastic bone resorption during estrogen deficiency. International journal of molecular medicine	K Strait, Y Li, DL Dillehay, MN Weitzmann	04/01/2008